MedPath

PENTA-TRIAZOLAM TABLETS

PENTA-TRIAZOLAM TABLETS

Discontinued
DIN Number

02232554

Drug Class

Human

Market Date

N/A

Company
HC

pentapharm ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02232554
AIG Number0112970002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD05 TRIAZOLAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRIAZOLAMActive
Strength: .25 MG / TAB
Monograph: TRIAZOLAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.